Victor S. Sloan, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Sloan VS. Aspirin in In-Flight Emergencies. Ann Intern Med. 1998;128:326. doi: 10.7326/0003-4819-128-4-199802150-00038
Download citation file:
Published: Ann Intern Med. 1998;128(4):326.
TO THE EDITOR:
The recent report by Saketkhou and colleagues  on the underuse of aspirin as the first therapy for patients admitted with a myocardial infarction reminds me of an experience I had on a flight from Chicago to New York several years ago. An elderly woman developed chest pain, apparently of cardiac nature, somewhere over western Ontario. On opening the medical kit, I was dismayed to find no aspirin. I later learned that the kit mandated by the Federal Aviation Administration for domestic carriers contains only 50% dextrose, epinephrine, diphenhydramine, nitroglycerin, a blood pressure cuff, stethoscope, syringes, needles, and oropharyngeal airways. Additional equipment may be added by the airline at its discretion .
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only